New innovation support centre to open in Hyderabad this month
The Centre for Cellular and Molecular Biology will set up a Common Research and Technology hub, which will work like an incubation centre to aid research
Hyderabad: The Centre for Cellular and Molecular Biology (CCMB) will set up this month a Common Research and Technology Hub, an innovation support centre which works on the lines of incubation centres to aid research, said CCMB director Mohan Rao on Thursday.
CCMB has already invested Rs.10 crore towards setting up the facility that can support around 20 start-ups, to begin with.
The hub will focus on areas of affordable health like personalized medicine, diagnostics, biopharmaceutics and medical devices.
The centre is a part of the Department of Scientific and Industrial Research initiative that aims to push micro and small and medium enterprises towards radical innovations through three such centres in the country.
The other two, at Kerala and Himachal Pradesh, are also being developed and awaiting applications from companies.
The other areas of research the three centres will be supporting include electronics, renewable energy, environmental interventions, low-cost machining and new materials.
The 10,000 square feet facility at Hyderabad will also have a clinical research and nanobiology facility.
“We are in talks with six companies now. The business models can be chosen between pay for usage, collaboration on investment, revenues and technology transfer. Companies would have access to not just the advanced scientific equipment, but also knowledge from CCMB,” said Rao, on the sidelines of a three-day conference on ‘NextGen Genomics, Biology, Bioinformatics and Technologies’, conducted by SciGenom Research Foundation in collaboration with CCMB and Institute of Bioinformatics.
“Even one mutation can cause a disease and personalized medicine has now become actionable. When gene sequencing for smaller groups like cancer patients is conducted, it becomes easier for patients to go to the doctor who can give them a medicine that treats them exclusively and not a blanket medicine,” said Dr George Thomas, director, SciGenom Research Foundation.
Editor's Picks »
- Policy rethink and higher volumes to aid container shippers
- DCB Bank delivers a strong Q2 but pressure on margins foreseen
- Havells India: Rising costs give a jolt to profitability in September quarter
- All’s well at Mindtree, except for high client concentration risk
- India’s rising steel demand is making companies starry-eyed